...
首页> 外文期刊>Balkan Medical Journal >The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
【24h】

The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study

机译:华法林在土耳其不同地理区域的治疗时间和出血并发症的时间:WARFARIN-TR研究的亚组分析

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: The time in therapeutic range values may vary between different geographical regions of Turkey in patients vitamin K antagonist therapy. Aims: To evaluate the time in therapeutic range percentages, efficacy, safety and awareness of warfarin according to the different geographical regions in patients who participated in the WARFARIN-TR study (The Awareness, Efficacy, Safety and Time in Therapeutic Range of Warfarin in the Turkish population) in Turkey. Study Design: Cross-sectional study. Methods: The WARFARIN-TR study includes 4987 patients using warfarin and involved regular international normalized ratio monitoring between January 1, 2014 and December 31, 2014. Patients attended follow-ups for 12 months. The sample size calculations were analysed according to the density of the regional population and according to Turkish Statistical Institute data. The time in therapeutic range was calculated according to F.R. Roosendaal’s algorithm. Awareness was evaluated based on the patients’ knowledge of the effect of warfarin and food-drug interactions with simple questions developed based on a literature review. Results: The Turkey-wide time in therapeutic range was reported as 49.5%±22.9 in the WARFARIN-TR study. There were statistically significant differences between regions in terms of time in therapeutic range (p0.001). The highest rate was reported in the Marmara region (54.99%±20.91) and the lowest was in the South-eastern Anatolia region (41.95±24.15) (p0.001). Bleeding events were most frequently seen in Eastern Anatolia (41.6%), with major bleeding in the Aegean region (5.11%) and South-eastern Anatolia (5.36%). There were statistically significant differences between the regions in terms of awareness (p0.001). Conclusion: Statistically significant differences were observed in terms of the efficacy, safety and awareness of warfarin therapy according to different geographical regions in Turkey.
机译:背景:在维生素K拮抗剂治疗患者中,土耳其不同地理区域的治疗时间范围值可能会有所不同。目的:根据参加WARFARIN-TR研究的患者的不同地理区域来评估华法林在治疗范围百分比,疗效,安全性和认识方面的时间(在华法林治疗范围内的认知,功效,安全性和时间)。土耳其人口)。研究设计:横断面研究。方法:WARFARIN-TR研究纳入了4987例使用华法令的患者,并于2014年1月1日至2014年12月31日之间进行了定期的国际归一化比率监测。患者接受了12个月的随访。根据区域人口的密度并根据土耳其统计研究所的数据对样本量计算进行了分析。治疗范围内的时间根据F.R. Roosendaal的算法。基于患者对华法林和食品与药物相互作用的了解,并根据文献综述提出了一些简单的问题来评估意识。结果:在WARFARIN-TR研究中,土耳其在治疗范围内的时间据报道为49.5%±22.9。在治疗范围内的时间方面,各区域之间存在统计学上的显着差异(p <0.001)。在马尔马拉地区报告的发生率最高(54.99%±20.91),在安纳托利亚东南部地区的发生率最低(41.95±24.15)(p <0.001)。出血事件最常见于安纳托利亚东部(41.6%),爱琴海地区(5.11%)和东南安纳托利亚东南部(5.36%)有大量出血。在意识方面,各区域之间存在统计学差异(p <0.001)。结论:根据土耳其不同地理区域,在华法林疗法的疗效,安全性和认识方面存在统计学差异。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号